BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 19 September 2014 at 11.30 a.m. Biotie: Selincro enters the market in France Biotie today announced that its partner H. Lundbeck A/S (Lundbeck) has brought Selincro(®) onto the market in France. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, Biotie is eligible for a milestone payment of EUR 2 million related to the market entry, which represents the final milestone for European market entries. Turku, 19 September 2014 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Investor Relations Manager tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com Distribution: NASDAQ OMX Helsinki Ltd Main Media www.biotie.com About Selincro (nalmefene): Selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (>60 g/day for men, >40 g/day for women) without physical withdrawal symptoms and who do not require immediate detoxification. Selincro should be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and the reduction of alcohol consumption. Treatment should be initiated only in patients who continue to have a high drinking risk level two weeks after an initial assessment. Selincro is to be taken as-needed; that is, on each day the patient perceives a risk of drinking alcohol, one tablet should be taken, preferably 1-2 hours prior to the anticipated time of drinking. Selincro received European marketing authorization in February 2013 and has to date been introduced in over 20 European markets. Biotie has licensed global rights to Selincro to Lundbeck. Under the terms of the agreement, Biotie is eligible for up to EUR 89 million in upfront and milestone payments plus royalties on sales of Selincro. Upon payment of the milestone for market entry in France, Biotie will have received EUR 22 million of such milestone payments from Lundbeck. Further potential milestone payments will become due on launches in certain other markets and if the product reaches certain predetermined sales. In addition, Biotie will continue to receive royalties on sales in all launched markets and will make a contribution to Lundbeck towards post approval commitments studies. Lundbeck is responsible for the registration, manufacturing and marketing of the product. About Biotie Biotie is a specialized drug development company focused on products for neurodegenerative and psychiatric disorders. Biotie's development has delivered Selincro (nalmefene) for alcohol dependence, which received European marketing authorization in 2013 and is currently being rolled out across Europe by partner Lundbeck. The current development products include tozadenant for Parkinson's disease, which is transitioning into Phase 3 development, and three additional compounds which are in Phase 2 development for cognitive disorders including Parkinson's disease dementia, cocaine dependence, and primary sclerosing cholangitis (PSC), a rare fibrotic disease of the liver. [HUG#1857023]
Biotie: Selincro enters the market in France BIOTIE
Top 10 Most Recent News Articles
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening
Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....
Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue ReadingTop 5 Most Recently Viewed Articles
Understanding the Latest Shareholder Disclosure by Rathbones Group
Key Shareholder Disclosure Overview In the dynamic world of finance and investments, understanding shareholder disclosures is crucial. Recently, a notable publication detailed the interests of Rathbones Group Plc related to Tritax Big Box REIT Plc. This form, often referred to as Form 8.3 under the Takeover Code, sheds light on significant positions held by entities...
Continue Reading
GraniteShares Launches New Short & Leveraged Stock ETFs
GraniteShares Expands Its Short & Leveraged ETF Range GraniteShares, a prominent ETF issuer known for its high-conviction investment products, has recently broadened its portfolio by launching three new short and leveraged single-stock ETFs. This expansion increases GraniteShares' total number of short and leveraged ETFs to 16, further solidifying its presence in the...
Continue Reading
Unlocking the Health Benefits of Beetroot Supplements
The Rise of Beetroot Supplements in Health and Fitness Beetroot supplements have gained significant popularity as powerful dietary aids. Known for their impressive health benefits, these supplements are making waves in both athletic and wellness communities. As more people seek natural ways to enhance their health and performance, MushCanyon leads the way with premium...
Continue Reading
AZIO AI Welcomes Chris Young as CEO to Accelerate Growth
AZIO AI Welcomes Chris Young as CEO to Accelerate Growth AZIO AI is poised for transformative expansion in the AI computing landscape with the appointment of Chris Young as the new Chief Executive Officer. This leadership transition comes at a crucial time for the company, reinforcing its trajectory as an independent entity focused on delivering innovative GPU clusters,...
Continue Reading
Glo Fiber Unveil Their High-Speed Internet in Ohio's Hillsboro
Glo Fiber's Launch of Fiber Internet in Hillsboro Glo Fiber, part of the Shenandoah Telecommunications Company (NASDAQ: SHEN), has officially rolled out its 100% fiber optic internet service in various neighborhoods in Hillsboro. This deployment is a significant milestone for the community, representing an investment in modern infrastructure that aims to enhance...
Continue Reading